The myelodysplastic syndromes: diagnosis, molecular biology and risk assessment (Q36270139)

13 August 2017

1 reference

title

The myelodysplastic syndromes: diagnosis, molecular biology and risk assessment (English)

1 reference

13 August 2017

0 references

John M Bennett

1

1 reference

PubMed ID

16188686

13 August 2017

Rami S Komrokji

series ordinal

2

1 reference

13 August 2017

1 September 2005

1 reference

13 August 2017

1 reference

13 August 2017

10 Suppl 1

1 reference

13 August 2017

258-269

1 reference

Proposals for the classification of the myelodysplastic syndromes

13 August 2017

1 reference

https://api.crossref.org/works/10.1080%2F10245330512331390311

Issues in the pathology and diagnosis of the chronic myeloproliferative disorders and the myelodysplastic syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10245330512331390311

21 January 2018

Clinical features of MDS

1 reference

https://api.crossref.org/works/10.1080%2F10245330512331390311

Chronic myelomonocytic leukaemia (CMML)--a myelodysplastic or myeloproliferative syndrome?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10245330512331390311

Refractory anemia with excess of blasts in transformation: analysis of reclassification according to the WHO proposals

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10245330512331390311

Hypocellular myelodysplastic syndromes (MDS): new proposals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10245330512331390311

DNA microarray analysis of stage progression mechanism in myelodysplastic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10245330512331390311

The World Health Organization (WHO) classification of the myeloid neoplasms

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10245330512331390311

The presence of clonal cell subpopulations in peripheral blood and bone marrow of patients with refractory cytopenia with multilineage dysplasia but not in patients with refractory anemia may reflect a multistep pathogenesis of myelodysplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10245330512331390311

A prognostic impact of separation of refractory cytopenia with multilineage dysplasia and 5q− syndrome from refractory anemia in primary myelodysplastic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10245330512331390311

Factors influencing survival in myelodysplastic syndromes in a Brazilian population: comparison of FAB and WHO classifications

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10245330512331390311

10.1080/10245330512331390311

21 January 2018

Identifiers

DOI

1 reference

13 August 2017

1 reference

PubMed ID

16188686